Veracyte, Inc.

22.94 USD
+0.40 (+1.77%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Veracyte, Inc. stock is up 10.29% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 81.82% of the previous 10 June’s closed higher than May.

About Veracyte, Inc.

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas. It is also developing Percepta Genome Atlas to help inform lung cancer treatment decisions.